First off, no-one yet knows what Galvin is thinking regarding the share structure, and how that could potentially fit into a RM - the 2018 (8-K) filing could be amended or completely changed.
No question the goal will be to raise the valuation, and with that the share price - the question is: how will this be accomplished?
If the theory pans out about the RM, this announcement alone will explode in the market, which will immediately grow the number of shareholders exponentially - what is an unknown is how Galvin wants the new public company (HYPR?) to be perceived coming out of the chute. This issue I believe will impact how the deal and RM is structured, which could potentially impact the overall share structure and when/if a change is made - could be on the front side, or after the PPS has grown organically to a specific trigger point.
All that said, if everything does fall in line, getting in at these levels into a company like HYPUR is an extraordinary opportunity, especially on the OTC Market - this too I believe is one of the critical issues that will be addressed: UPLISTING, and potentially could be onto a listed exchange!
I'm thinking we'll know where everything is going by the end of this month - GOOD LUCK TO ALL OF US!